DBXA 📈 Xtrackers MSCI Europe - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274209237 • Europe Large-Cap Blend Equity
DBXA: Stocks, Bonds, European, Equities
The Xtrackers MSCI Europe UCITS ETF 1C, listed on XETRA as DBXA, is a financial instrument that provides exposure to the European equity market. It is issued by DWS, a global asset manager with a presence in multiple regions, and its company URL is http://www.dws.lu. The fund is domiciled in Luxembourg, which is a common location for European investment funds due to its favorable regulatory environment and tax efficiency.
This ETF tracks the Morningstar DM Eur TME NR EUR index, which is designed to capture the performance of large-cap companies in the European developed market. The index is a market-capitalization-weighted index, meaning that the largest companies in the index have a greater influence on its performance. The fund's ISIN is LU0274209237, which is a unique identifier used to identify the security and facilitate trading. As an ETF, it is listed on an exchange and can be bought and sold like a stock, providing investors with flexibility and transparency.
The Xtrackers MSCI Europe UCITS ETF 1C falls under the Europe Large-Cap Blend Equity category, which means it invests in a diversified portfolio of large-cap companies across various sectors and industries in Europe. This type of fund is often used by investors seeking long-term growth and diversification in their portfolios. By tracking a broad market index, the fund provides exposure to a wide range of companies, reducing the risk associated with individual stocks and sectors. The fund's UCITS compliance ensures that it meets certain regulatory requirements and standards, providing an additional layer of investor protection.
Additional Sources for DBXA ETF
DBXA ETF Overview
Market Cap in USD | 3,568m |
Category | Europe Large-Cap Blend Equity |
TER | 0.13% |
IPO / Inception | 2007-01-10 |
DBXA ETF Ratings
Growth 5y | 57.4% |
Fundamental | - |
Dividend | 3.0% |
Rel. Strength Industry | 156 |
Analysts | - |
Fair Price Momentum | 81.89 EUR |
Fair Price DCF | - |
DBXA Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 10.0% |
DBXA Growth Ratios
Growth Correlation 3m | -47.5% |
Growth Correlation 12m | 66.7% |
Growth Correlation 5y | 90.7% |
CAGR 5y | 6.38% |
CAGR/Mean DD 5y | 1.06 |
Sharpe Ratio 12m | 0.42 |
Alpha | -11.20 |
Beta | 0.66 |
Volatility | 15.80% |
Current Volume | 23.8k |
Average Volume 20d | 18.7k |
As of December 27, 2024, the stock is trading at EUR 88.63 with a total of 23,835 shares traded.
Over the past week, the price has changed by -0.75%, over one month by -0.52%, over three months by -4.11% and over the past year by +7.73%.
Partly, yes. Based on ValueRay Analyses, Xtrackers MSCI Europe (XETRA:DBXA) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.39 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXA as of December 2024 is 81.89. This means that DBXA is currently overvalued and has a potential downside of -7.6%.
Xtrackers MSCI Europe has no consensus analysts rating.
According to ValueRays Forecast Model, DBXA Xtrackers MSCI Europe will be worth about 90.1 in December 2025. The stock is currently trading at 88.63. This means that the stock has a potential upside of +1.64%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 90.1 | 1.6% |